Submitted by Anonymous (not verified) on 4 June 2025 - 14:58
Human medicines European public assessment report (EPAR): Beqvez (previously Durveqtix), fidanacogene elaparvovec, Date of authorisation: 24/07/2024, Revision: 3, Status: Withdrawn
Source:
